Home › NDC Lookup › RxCUI directory › RxCUI 238082

Ketamine 10 MG/ML Injectable Solution — RxCUI 238082

RxNorm drug concept · Semantic clinical drug
RxCUI 238082 Semantic clinical drug · SCD ● Current RxNorm concept 16 FDA products 16 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI238082
Official nameKetamine 10 MG/ML Injectable Solution
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asketamine (as ketamine hydrochloride) 10 MG/ML Injectable Solution
FDA products mapped16
Package NDCs mapped16
Reported Medicaid activity (SDUD)3,135 prescriptions · 20 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Ketamine: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • The FDA-approved use of ketamine injection is as a general anesthetic — it's given in hospitals and surgical centers to put people into a deep sedated state for procedures, either...
  • What exactly is ketamine used for — I keep hearing about it in the news but my doctor says it's for surgery?
  • Ketamine creates what's called a 'dissociative' state — you won't feel pain and you'll be deeply sedated, but it works a little differently from traditional anesthesia. Your protec...
  • Will I be completely unconscious, or will I know what's happening?
📖 Read our full Ketamine guide →

🕸️ Concept Web — How Ketamine 10 MG/ML Injectable Solution Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Ketamine 10 MG/ML Injectable Solution RxCUI 238082

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Ketamine 6130
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Ketalar 6129
  3. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Ketamine Injectable Solution 372528
    • Ketamine Injectable Product 1160946
    • Ketamine Injectable Solution [Ketalar] 362689
    • Ketalar Injectable Product 1170704
    • Injectable Solution 316949
    • Injectable Product 1151126
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Ketamine 10 MG/ML SCDC · 330467
  • Ketamine Injectable Solution SCDF · 372528
  • Ketamine Injectable Product SCDG · 1160946

Brand-Name Concepts

📦 FDA Products & Package NDCs

16 products · 16 package NDCs
16 package NDCs map to RxCUI 238082 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00404-9880-20 1 VIAL in 1 BAG (0404-9880-20) / 20 mL in 1 VIAL KETALAR Henry Schein, Inc 2022-01-11
25021-0682-20 10 VIAL in 1 CARTON (25021-682-20) / 20 mL in 1 VIAL Ketamine Hydrochloride Sagent Pharmaceuticals 2023-07-15
25021-0683-10 10 VIAL in 1 CARTON (25021-683-10) / 10 mL in 1 VIAL Ketamine Hydrochloride Sagent Pharmaceuticals 2023-07-15
25021-0684-05 10 VIAL in 1 CARTON (25021-684-05) / 5 mL in 1 VIAL Ketamine Hydrochloride Sagent Pharmaceuticals 2023-07-15
42023-0113-10 10 VIAL in 1 CARTON (42023-113-10) / 20 mL in 1 VIAL Ketalar Par Health USA, LLC 2007-10-01
42023-0114-10 10 VIAL in 1 CARTON (42023-114-10) / 10 mL in 1 VIAL Ketalar Par Health USA, LLC 2007-10-01
42023-0115-10 10 VIAL in 1 CARTON (42023-115-10) / 5 mL in 1 VIAL Ketalar Par Health USA, LLC 2007-10-01
55150-0438-10 10 VIAL, MULTI-DOSE in 1 CARTON (55150-438-10) / 20 mL in 1... KETAMINE HYDROCHLORIDE Eugia US LLC 2021-03-15
55150-0439-10 10 VIAL, MULTI-DOSE in 1 CARTON (55150-439-10) / 10 mL in 1... KETAMINE HYDROCHLORIDE Eugia US LLC 2021-03-15
55150-0440-10 10 VIAL, MULTI-DOSE in 1 CARTON (55150-440-10) / 10 mL in 1... KETAMINE HYDROCHLORIDE Eugia US LLC 2021-03-15
65219-0184-20 10 VIAL in 1 TRAY (65219-184-20) / 20 mL in 1 VIAL (65219-1... ketamine hydrochloride Fresenius Kabi USA, LLC 2023-07-10
65219-0186-05 10 VIAL in 1 TRAY (65219-186-05) / 5 mL in 1 VIAL (65219-18... ketamine hydrochloride Fresenius Kabi USA, LLC 2025-04-18
65219-0188-10 10 VIAL in 1 TRAY (65219-188-10) / 10 mL in 1 VIAL (65219-1... ketamine hydrochloride Fresenius Kabi USA, LLC 2023-07-10
68083-0504-10 10 VIAL in 1 CARTON (68083-504-10) / 20 mL in 1 VIAL Ketamine Hydrochloride Gland Pharma Limited 2023-01-24
68083-0505-10 10 VIAL in 1 CARTON (68083-505-10) / 10 mL in 1 VIAL Ketamine Hydrochloride Gland Pharma Limited 2023-01-24
68083-0506-10 10 VIAL in 1 CARTON (68083-506-10) / 5 mL in 1 VIAL Ketamine Hydrochloride Gland Pharma Limited 2023-01-24
Observed labelers: Eugia US LLC (3) · Fresenius Kabi USA, LLC (3) · Gland Pharma Limited (3) · Par Health USA, LLC (3) · Sagent Pharmaceuticals (3) · Henry Schein, Inc (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.